Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131998) titled 'Application of Molecular Consultation in the Diagnosis and Treatment of Neurogenetic Metabolic Diseases' on Sept. 8.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Xuanwu Hospital Capital Medical University
Condition:
Neurogenetic and neurometabolic disorders
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-10
Target Sample Size: MMC-confirmed case group:700;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=342085
Published by HT Digital Content Services with permission from Health Daily D...